HENLIUS(02696.HK): Completes H-Share Full Circulation, 182.65 Million Unlisted Shares Converted to H-Shares to List Tomorrow
NewTimeSpace News: HENLIUS(02696.HK) issued a notice on February 4, 2026, disclosing that the company’s H-share full circulation has been officially completed. The notice shows that a total of 182.6459 million unlisted shares have been fully converted to H-shares, with the conversion process successfully concluding on February 4, 2026. These converted H-shares will be officially listed on the HKEX and incorporated into the H-share trading system at 9:00 a.m. (Hong Kong Time) on February 5, 2026.
In terms of shareholding structure, HENLIUS’total share capital remains unchanged at 543.4949 million shares before and after the completion of the conversion and listing, with only adjustments to the proportion of different share classes.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HENLIUS (02696.HK): Added as Hang Seng Composite Index Constituent, Effective 7 September
- Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
- HENLIUS (02696.HK): enters global strategic partnership with Sandoz covering up to 10 biosimilar products, with upfront and milestone payments totaling up to USD 314 million
- Henlius (02696.HK): NMPA Approves Clinical Trial Application for HLX43 Combined with Bevacizumab in Solid Tumors
- Henlius (02696.HK): First Patient Dosed in Phase 1 Trial of Trispecific Antibody HLX3902 Targeting STEAP1×CD3×CD28